J. Bradley White

The Impact Of Stronger Drug Dosing Patents On Canadian Drug Access

U.K. Appellate Court Rules Artificial Neural Network Application Is Not Patent-Eligible Subject Matter

Canadian Intellectual Property Office (CIPO) Increasing Official Fees Effective January 1, 2024

Canadian Court Again Rejects Problem-solution Approach To Subject-matter Eligibility Of Computer-implemented Patents

Act Now: Request Examination Early To Avoid Excess Claims Fees And Other Restrictions Under Proposed New Canadian Patent Rules

Canadian Courts Are Interpreting Supplementary Pharmaceutical Patent Protection More Broadly Than Their EU Counterparts

Choueifaty Patent Application Found To Possess Patentable Subject-matter

Canadian Patent Office Issues Guidance On Computer-implemented And Medical Inventions Following Choueifaty Decision

Federal Court Invalidates Tadalafil Dosage Patent Finding Dose Selection To Be Routine

Intellectual Property Litigation In The Federal Court